Baruch et al.13 found that 10 malignant Melanoma patients with PD-1/PD-L1 immunotherapy resistance received fecal microbiome transplantation (FMT), one of whom was completely relieved, and two of whom were partially relieved. This evidence concerns the gene CD274 and melanoma.